ST Robotics Reports They Are Increasing Their Laboratory Robotics Production to Meet Demand from COVID-19

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

GenesisCare Orders 27 Elekta Flexitron Treatment Devices

"GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide and Elekta is delighted to play a vital partnering role to achieve this mission," said Gustaf Salford, Elekta's President and CEO.

FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial

SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.

Today ST Robotics reported they are ramping up its shipments of four, five and six-axis industrial robots, in response to the recent increase in demand from COVID-19.

ST Robotics notes that Mesa Labs in Montana is using the ST Robotics systems to increase production and maximize flexibility for the vapor hydrogen peroxide sterilization of its Apex biological indicator (BI) products.  To meet their client demands in the fight against COVID-19, Mesa Labs is in the process of implementing another ST robotic arm that is specifically designed for a medical device manufacturer of personal protective equipment (PPE).

“By using ST Robots, we save 22 hours of direct labor per day.   ST Robotics is wonderful to work with and their products have been a great investment for our product lines,” commented Nicholas Spain, Mesa Labs Senior Manager of Manufacturing.

ST Robotics has been a successful producer in laboratory robotics since 1993.  Their customers include major pharmaceutical companies and research institutes, including the National Institutes of Health (NIH), the Wellcome Sanger Institute, Pfizer, GlaxoSmithKline (GSK), and Eli Lilly.  ST Robotics improves the automation of everything from polymerase chain reaction (PCR) to high-throughput screening in forensic science, drug development, bacterial resistance, toxicology, stem cell research, and other fields.  The UK Forensic Science Service set up the largest national DNA database in the world using eight ST robots.

“Even today, we are still able to solve those difficult laboratory automation problems that no-one else can solve,” says David Sands, Founder CEO at ST Robotics. “Moreover, because of our vast experience in the demanding world of manufacturing, we can offer the lab market a totally reliable workhorse of a robot, together with software and hardware that enables us to interface with any other instruments or devices.”  Sands also founded the European branch of the Laboratory Robotics Interest Group (ELRIG) in 2001.

According to a new report by Market Watch, The Global Lab Automation Market is expected to exceed more than US$ 8 Billion by 2027 at a CAGR of 6.5%.

spot_img

DON'T MISS

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.